Efficacy of newer agents in the glycaemic management of patients with type 2 diabetes

被引：2
|
作者：
Chudleigh, Richard A. [1 ]
Bain, Steve C. [2 ]
机构：
[1] Swansea Bay Univ Hlth Board, Singleton Hosp, Swansea, W Glam, Wales
[2] Swansea Univ, Med Sch, Diabet Res Unit Cymru, Swansea, W Glam, Wales
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2020年 / 36卷 / 02期
关键词：
ONCE-DAILY LIRAGLUTIDE; CARDIOVASCULAR OUTCOMES; OPEN-LABEL; EXENATIDE; METFORMIN; SAFETY; CANAGLIFLOZIN; LIXISENATIDE; SITAGLIPTIN; DULAGLUTIDE;
D O I：
10.1080/03007995.2019.1678344
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：209 / 211
页数：3
相关论文
共 50 条
  • [1] Glycaemic management of type 2 diabetes
    Page, S
    CLINICAL MEDICINE, 2004, 4 (04) : 302 - 306
  • [2] PATIENTS' PREFERENCES FOR NEWER SECOND-LINE PHARMACOLOGICAL AGENTS IN TYPE 2 DIABETES
    Banjara, B.
    Poudel, N.
    Garza, K. B.
    Westrick, S. C.
    Whitley, H. P.
    Ngorsuraches, S.
    VALUE IN HEALTH, 2022, 25 (07) : S566 - S566
  • [3] Editorial: Newer peptide-based agents for treatment of patients with Type 2 diabetes
    Flatt, Peter R.
    Conlon, J. Michael
    PEPTIDES, 2018, 100 : 1 - 2
  • [4] Positioning newer drugs in the management of type 2 diabetes
    Marx, Nikolaus
    Davies, Melanie J.
    Grant, Peter J.
    Mathieu, Chantal
    Petrie, John R.
    Cosentino, Francesco
    Buse, John B.
    LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (03): : 139 - +
  • [5] Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis
    De Groot, Julia
    Wu, Dongjun
    Flynn, Declan
    Robertson, Dylan
    Grant, Gary
    Sun, Jing
    WORLD JOURNAL OF DIABETES, 2021, 12 (02) : 170 - 197
  • [6] Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes
    de Bhailis, Aine M.
    Azmi, Shazli
    Kalra, Philip A.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2021, 12
  • [7] Trends in Type 2 Diabetes Pharmacotherapy and Evolving Use of the Newer Agents
    Bae, Jay P.
    Liu, Dongju
    Chinthammit, Chanadda
    Kadziola, Zbigniew A.
    Boye, Kristina
    Mather, Kieren J.
    DIABETES, 2021, 70
  • [8] Glycaemic management in type 1 and 2 diabetes patients undergoing interventional cardiology procedures
    Alonso-Garcia, Angeles
    Moreno Gomez, Raul
    Miranda Guardiola, Faustino
    Artola-Menendez, Sara
    Lisbona-Gil, Arturo
    MEDICINA CLINICA, 2012, 138 (05): : 207 - 207
  • [9] Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes and inadequate glycaemic control on sitagliptin
    Kaku, Kohei
    Kadowaki, Takashi
    Seino, Yutaka
    Okamoto, Taro
    Shirakawa, Masayoshi
    Sato, Asako
    O'Neill, Edward A.
    Engel, Samuel S.
    Kaufman, Keith D.
    DIABETES OBESITY & METABOLISM, 2021, 23 (09): : 2099 - 2108
  • [10] SAFETY AND EFFICACY OF STANDARDISED GLYCAEMIC MANAGEMENT BY USING THE GLUCOTAB SYSTEM FOR PATIENTS WITH DIABETES MELLITUS TYPE 2 AT DIFFERENT HOSPITAL WARDS
    Neubauer, K. M.
    Aberer, F.
    Mader, J. M.
    Hoell, B.
    Schaupp, L.
    Spat, S.
    Beck, P.
    Donsa, K.
    Plank, J.
    Pieber, T. R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A26 - A26
12345